Every story in this section, newest first — page 243 of 373.
The Dixie Group (NASDAQ:DXYN), a prominent developer and manufacturer of high-end floor covering products, today reported financial results for the fourth quarter and full year ended December 31, 2025.
Aptevo Therapeutics (NASDAQ:APVO), a clinical-stage biopharmaceutical company focused on developing novel bispecific and multispecific immunotherapies for cancer, today reported financial results for the year ended December 31, 2025, and provided a strategic business update.
Cognition Therapeutics (NASDAQ:CGTX), a clinical-stage biopharmaceutical company developing next-generation therapies for neurodegenerative disorders, today reported financial results for the full year ended December 31, 2025, and provided a comprehensive update on its lead candidate, zervimesine (CT1812).
REX American Resources (NYSE:REX), a player in the U.S. ethanol industry, today reported financial results for its fiscal fourth quarter and full year ended January 31, 2026.
MapLight Therapeutics (NASDAQ:MPLT), a biopharmaceutical company focused on circuit-specific therapies for central nervous system (CNS) disorders, today reported financial results for the fourth quarter and full year ended December 31, 2025.
Acumen Pharmaceuticals (NASDAQ:ABOS), a clinical-stage biopharmaceutical company developing a novel targeted immunotherapy for Alzheimer’s disease, today reported financial results for the full year ended December 31, 2025, and provided a comprehensive business update.
The Lovesac Company (NASDAQ:LOVE), the omni-channel home brand famous for its "Designed for Life" Sactionals, today announced financial results for the fourth quarter and full fiscal year ended February 1, 2026.
WhiteFiber (NASDAQ:WYFI), a vertically integrated provider of artificial intelligence (AI) infrastructure and high-performance computing (HPC) solutions, today reported its financial results for the fourth quarter and full year ended December 31, 2025.
Commercial Metals Company (NYSE:CMC), a global leader in innovative solutions for the built environment, today reported financial results for its fiscal second quarter ended February 28, 2026.
Designer Brands (NYSE:DBI), the parent company of DSW and a global leader in brand development and footwear retail, today reported its financial results for the fourth quarter and full fiscal year ended January 31, 2026.
Worthington Steel (NYSE:WS), a value-added metals processor, today reported financial results for its fiscal 2026 third quarter ended February 28, 2026.
Immersion (NASDAQ:IMMR), the Aventura, Florida-based developer of touch-feedback technology, reported a fiscal first-quarter net loss of $930,000, or $0.03 per diluted share.
Shoe Carnival (NASDAQ:SCVL), a leading family footwear retailer, today announced its financial results for the fourth quarter and fiscal year ended January 31, 2026.
22nd Century Group (NASDAQ:XXII), a leading agricultural biotechnology company dedicated to tobacco harm reduction and reduced-nicotine tobacco, today reported its financial results for the fourth quarter and full year ended December 31, 2025.
Lumexa Imaging (NASDAQ:LMRI), a premier provider of outpatient diagnostic imaging services, today announced its preliminary, unaudited financial results for the fourth quarter and full year ended December 31, 2025.
Rockwell Medical (NASDAQ:RMTI), a healthcare company focused on the manufacturing and distribution of life-sustaining hemodialysis products, today announced its financial results for the fourth quarter and full year ended December 31, 2025.
Pony.ai (NASDAQ:PONY), a global pioneer in autonomous mobility, today announced its financial and operational results for the fourth quarter and full year ended December 31, 2025.
Pony.ai (NASDAQ:PONY), a global leader in autonomous mobility, and Uber Technologies (NYSE:UBER) have announced a strategic partnership with the European service operator Verne to launch the first commercial robotaxi service in Europe.
Ascentage Pharma (NASDAQ:AAPG), a global biopharmaceutical company developing novel therapies for cancers, hepatitis B virus, and age-related diseases, announced its unaudited financial results for the year ended December 31, 2025.
OLAPLEX Holdings (NASDAQ:OLPX), the innovative science-led hair care brand, announced today that it has entered into a definitive agreement to be acquired by the German consumer goods giant Henkel.
Noah Holdings (NYSE:NOAH), a wealth management service provider for global Chinese high-net-worth investors, today announced financial results for the fourth quarter and full year ended December 31, 2025.
PDD Holdings (NASDAQ:PDD) reported its unaudited financial results for the fourth quarter and full year ended December 31, 2025, on Wednesday, revealing a narrative of steady top-line expansion tempered by the rising costs of its global ambitions.
Corcept Therapeutics Incorporated (NASDAQ:CORT), a commercial-stage company pioneering the modulation of cortisol to treat severe disorders, today announced that the U.S. Food and Drug Administration (FDA) has approved Lifyorli™ (relacorilant).
Denali Therapeutics (NASDAQ:DNLI), a biopharmaceutical company dedicated to developing a broad portfolio of product candidates engineered to cross the blood-brain barrier (BBB), announced today that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for AVLAYAH™ (tividenofusp alfa-eknm).
